Radical improvements in diagnostic services, cancer education, and training, and policies that encourage integration between primary and specialist care, primary care doctors could hold the key to meeting the growing demand for cancer care.
Working with tissue, blood, and DNA from six people with precancerous and cancerous lung lesions, scientists identified what they believe are the very earliest premalignant genetic changes that mark the potential onset of lung cancer.
Cancer specialists have long looked at genetic mutations and DNA copy changes to predict patient survival and drug sensitivity. A study has opened up yet another avenue for understanding why some people live longer or respond better to treatment.
Brentuximab vedotin is proven an effective and safe first course of treatment for older patients with Hodgkin lymphoma who are not candidates for chemotherapy.
Researchers are working on a way to use artificial intelligence to predict a patient's response to two common chemotherapy drugs used to treat breast cancer: paclitaxel and gemcitabine.